Z-2169-2017Class III
AIA-PACK TgAb CONTROL SET
Tosoh Bioscience Inc / initiated 2017-02-08 / Terminated / root cause: labeling and UDI
Tosoh Bioscience, Inc. began a recall of AIA-PACK TgAb CONTROL SET on . FDA classified it as Class III and gives the reason as "The label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (AIA). Two sets of instructions were...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-2169-2017
- Classification
- Class III
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Tosoh Bioscience Inc
- Product
- AIA-PACK TgAb CONTROL SET
- Product code
- JZO System, Test, Thyroid Autoantibody
- Reason for recall
- The label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (AIA). Two sets of instructions were included on the label.
- Root cause tag
- labeling and UDI
- FDA root cause
- Labeling mix-ups
- Action
- On 3/3/2017 the firm sent recall notificaion letters to their customers.
- Quantity in commerce
- 64 boxes
- Distribution
- Product was shipped to the following states: AK, FL, GA, MA, NY, NY, OH, OK & TX.
- Product codes and lots
- TgAb: G644899 Expires June 2017; G844801 Expires August 2017 & GX44802 Expires 09/30/2017.
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2168-2017 | Class III | Terminated | Voluntary: Firm initiated | ||
| Z-2169-2017 | Class III | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
